as on December 9, 2025 at 7:59 am IST
Day's Low
Day's High
0.51%
Downside
0.33%
Upside
52 Week's Low
52 Week's High
41.81%
Downside
4.94%
Upside
Check Akero Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$-
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Akero Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $- | NA | NA | 0.00% | |
| BUY | $35.2B | 319.73% | -16.34 | -210.54% | |
| BUY | $44.6B | 119.43% | 144.91 | 8.45% | |
| BUY | $121.1B | 120.34% | 31.15 | 32.94% | |
| BUY | $82.4B | 66.59% | 18.8 | 31.41% |
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Akero Therapeutics Inc. Average target price of $56
Get share price movements and forecasts by analysts on Akero Therapeutics Inc.
What analysts predicted
2.41%UPSIDE
Target Price
$56
Current Price
$54.65
Analyzed by
16 Analysts
Target
$56.00
Akero Therapeutics Inc target price $56, a slight upside of 2.41% compared to current price of $54.65. According to 16 analysts rating.
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 10 October
Fri, 04:29 PM
-Akero agrees to a $5.2 billion takeover by Novo Nordisk, enhancing its position in metabolic treatments.
Sat, 04:08 AM
-Analyst downgrades Akero to Hold with a $58 price target amid regulatory uncertainties post-Novo acquisition.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 year, AKRO stock has moved up by 80.1%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 951.8% return, outperforming this stock by 924.6%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 161.7% return, outperforming this stock by 81.6%
| Organisation | Akero Therapeutics Inc |
| E-voting on shares | Click here to vote |
Akero Therapeutics Inc share price today is $54.65 as on at the close of the market. Akero Therapeutics Inc share today touched a day high of $54.83 and a low of $54.37.
Akero Therapeutics Inc share touched a 52 week high of $57.35 on and a 52 week low of $31.8 on . Akero Therapeutics Inc stock price today i.e. is closed at $54.65,which is 4.71% down from its 52 week high and 71.86% up from its 52 week low.
Indian investors can start investing in Akero Therapeutics Inc (AKRO) shares with as little as ₹90.681 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.81 in Akero Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Akero Therapeutics Inc share’s latest price of $54.65 as on December 9, 2025 at 2:29 am IST, you will get 0.1830 shares of Akero Therapeutics Inc. Learn more about
fractional shares .